This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Court of Justice of the EU (the Court) has overturned the General Court’s judgment in Illumina/Grail, effectively putting an end to the EC’s revised Article 22 policy approach for below-threshold mergers.
This article is part of Fenwick's "Buy-Side M&A Playbook" series, published as part of the Silicon Valley Defense Group's Industry Collaboration Toolkit. By: Fenwick & West LLP
The Court of Appeal has upheld a High Court decision regarding the interplay between potentially conflicting provisions in a company’s articles of association. The provisions in question related to the conversion of shares and variation of class rights.
In this article we examine recent developments in Europes largest economies including the UK, Germany, and France where significant. This in turn will have a significant impact on both investment activity in the defence supply chain and how these products and services are procured. By: Hogan Lovells
Alex Barrage, a partner with Troutman Pepper Locke, was quoted in the January 9, 2025 American Banker article, CFPB Rules, M&A Standards Most Likely CRA Repeal Targets.. By: Troutman Pepper Locke
Pursuant to Article 45-A of the Public Health Law (PHL) (referred to in the FAQs as the "Material Transactions Law"), "health care entities" (HCEs) involved in a "material transactions" are obligated to provide written notice to DOH at least 30 days prior to the closing of the transaction.
As part of our series on trademarks as critical assets for businesses, this article discusses the importance of selecting and clearing a new or altered trademark for use and registration in the United States.
The AG assessed whether the European Commission (EC) has jurisdiction (under its revised “Article 22” referrals policy) to review transactions where neither EU nor national merger control notification thresholds are met. He advised the EU’s top court to rule that the EC does not.
ComplexDiscovery’s Editor’s Note: This article provides a detailed analysis of the July 2024 HSR transaction data and key economic indicators, emphasizing their impact on the eDiscovery sector.
This article explores the implications, highlighting the need for proactive inventorship inquiries to navigate the complexities of AI-driven innovation. Artificial intelligence is revolutionizing life science R&D (particularly in the realm of drug discovery) and challenging the traditional "human inventorship" requirement for U.S.
This article discusses compliance “Buy America” provisions in federal procurement laws and how the Federal Acquisition Regulations (FAR) implement some of those commitments in government contracts.
On June 2, 2025, the European Commission (EC) announced that it had fined food delivery companies Delivery Hero and Glovo a total of €329 million for participating in a cartel in the online food delivery sector in violation of Article 101(1) of the Treaty on the Functioning of the European Union (TFEU).
In this article, we set out how competition law considerations may be relevant to the development and utilisation of AI systems by market participants and examine how competition authorities are anticipating and preparing to address the new challenges posed by the widespread adoption of AI systems.
I began writing about Nevada Corporate Law more than three decades ago with an article entitled "The Nevada Corporation: Is It A Good Bet?". In the ensuing decades, I have published several more articles, numerous blog posts, and treatises on Nevada corporate law under three different publishers.
This latest edition features an interview with retiring longtime Wilson Sonsini IP partner Vern Norviel and articles on MedTech and pharma trends for 2025, the eligibility of life sciences companies for qualified small business stock, what life sciences companies need to know about brands, double-patenting jeopardy, and life sciences venture financings (..)
James Stevens, co-leader of Troutman Pepper Lockes Financial Services Industry Group, was quoted in the March 5, 2025 Banking Dive article, FDIC Withdraws Merger Policy, Brokered Deposits Proposal.. By: Troutman Pepper Locke
COMPETITION - Action brought on 10 January 2025 - Nvidia Vs. Commission (Case T-15/25) Re: annulment of Commissions decision on the request for referral by Italy to the Commission pursuant to Article 22(1) of the EUMR and Article 57 of the EEA Agreement, in Case M.11766, 11766, NVIDIA / Run:ai. By: Mayer Brown
We had previously questioned whether the new approach to Article 22 EUMR followed by the EC would herald a new era in EU merger control, leading to an increased number of deals being reviewed, and more importantly an increased number of significant investigations. By: Dechert LLP
In this article from The Threshold, the authors recap a panel on theories of labor harm in mergers, sponsored by the Mergers and Acquisitions Committee of the American Bar Association Section of Antitrust Law. By: Cornerstone Research
This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements about antitrust issues. In this installment, we discuss notable takeaways from the agency's recent enforcement action on "gun jumping." Originally published in Law360 - February 5, 2025. By: Proskauer Rose LLP
The newsletter is a curation of published articles and news, and contains original content developed by AGGs Bankruptcy, Creditors Rights, & Financial Restructuring attorneys. AGGs Restructuring Roundup newsletter is a monthly update of legal issues and news affecting or related to commercial litigation and bankruptcy.
In this article, we provide an overview of the new regime and provide a comparison with the corresponding notification deadlines in the EU and UK. On September 30, 2024, the revised Schedule 13G filing deadlines became effective. By: McDermott Will & Emery
Editor’s Note: The article below is the first in our three-part series, Federal Antitrust Enforcement in Health Care: 2023 Year in Review. The series is based on our recent webinar, 2023 Health Care Enforcement Trends: Spotlight on Consumer Protection, Antitrust and Fraud. By: Manatt, Phelps & Phillips, LLP
This article highlights takeaways from the final two days of the Spring Meeting. The annual Spring Meeting featured updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. By: McDermott Will & Emery
With its eagerly-awaited Illumina/Grail judgment on 3 September 2024, the Court of Justice of the European Union (“ECJ”) closed a transatlantic saga and rejected the European Commission's ("Commission") extended interpretation of Article 22 of the EU Merger Control Regulation ("EUMR") by finding that the Commission had no right to receive referrals (..)
This article provides a comprehensive overview of the legal framework and practical steps involved in effectuating a business conversion to Florida, ensuring continuity while establishing a new. Florida has long been a magnet for businesses seeking a favorable economic climate, lower tax burdens, and a pro-business regulatory environment.
This article addresses the legal and practical issues for lenders on leveraged buy-outs in relation to taking security over warranty and indemnity insurance policies. This article first appeared in the March issue of Butterworths Journal of International Banking and Financial Law. By: Hogan Lovells
In June we circulated an article entitled “Mid-year assessment: Are you in good shape on CTA compliance?” The Corporate Transparency Act (CTA) deadline for filing BOI reports with FinCEN is now less than three months away – any “reporting company” formed before 2024 must file its BOI report on or before January 1, 2025. By: Verrill
In another article, we outline potential pitfalls for companies that want to lend financial support to political conventions, transitions or inaugural events in this U.S. election year. By: Skadden, Arps, Slate, Meagher & Flom LLP
This article, the first in a multi-part series on M&A in insurance, considers the change of control regime under the Bermuda Insurance Act 1978 (the “Insurance Act”) as it applies to shareholder controllers of Bermuda insurers. By: Carey Olsen
This article discusses the requirements for. Involuntary petitions are an extreme remedy, and therefore the requirements and standards to meet for filing such petitions are strictly construed and applied. By: Troutman Pepper
This article provides insights into the antitrust enforcement activities and legislative developments that took place in China in 2023 and offer a forecast of what we can expect in the year ahead, taking into account the Report and the developments observed in the first half of 2024.
We also include links to our articles, blogs, and webinars with more analysis in these areas. Welcome to Wiley’s update on recent developments and what’s next in consumer protection at the Consumer Financial Protection Bureau (CFPB) and Federal Trade Commission (FTC). By: Wiley Rein LLP
In this issue, you’ll find informative articles covering non-disclosure agreements, associate buy-ins, and crucial cybersecurity and privacy practices for veterinary clinics. Exciting news from the National Veterinary Law Group at Mandelbaum Barrett PC!
On September 3, 2024, the EU’s highest court, the European Court of Justice (ECJ), ruled that the European Commission (EC) had no jurisdiction to review Illumina’s acquisition of Grail, overturning the EU’s revised Article 22 policy.
According to an article in the Wall Street Journal on April 18, 2024, 12 states have already passed legislation regulating private equity involvement in healthcare. State legislatures across the country are beginning to consider and debate the pros and cons of passing laws aimed at regulating private equity’s role in the healthcare industry.
COMPETITION - Summary of Commission Decision of 28 June 2021 pursuant to Article 7 of Council Regulation (EC) No 1/2003 in Case AT.39914 39914 - Euro Interest Rate Derivatives - Opinion of the Advisory Committee on restrictive agreements and dominant positions & Final Report of the Hearing Officer. By: Mayer Brown
We also include links to our articles, blogs, and webinars with more analysis in these areas. Welcome to Wiley’s update on recent developments and what’s next in consumer protection at the Consumer Financial Protection Bureau (CFPB) and Federal Trade Commission (FTC). By: Wiley Rein LLP
Many acquisitions, especially privatisations, are structured as a statutory merger, and in this article, we provide a brief overview of Cayman Islands (“Cayman”) mergers and consolidations and the general requirements for each under Cayman law. By: Conyers
As the UK Government seeks to put sustainability at the heart of the beautiful game, in this article we consider: The Bill’s introduction to Parliament represents the culmination of several years of UK Government activity focused on increasing regulation in men’s football. By: Allen & Overy LLP
While Chris van Heerden’s recent article gave some cause for optimism over the fundraising environment for 2024, for now on the ground we are continuing to see significantly longer lead times before funds hit their target size, even for top-tier sponsors. By: Cadwalader, Wickersham & Taft LLP
The New York State Department of Health has published a webpage regarding Public Health Law (PHL) Article 45-A. In our prior post, we discussed how PHL Article 45-A requires health care entities involved in material transaction(s) to provide written notice and information to DOH at least 30 days prior to the closing of a covered transaction.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content